Autek China Inc. (SHE:300595)
10.02
+0.07 (0.70%)
Sep 14, 2026, 3:04 PM CST
Autek China Revenue
Autek China had revenue of 405.76M CNY in the quarter ending June 30, 2026, with 3.38% growth. This brings the company's revenue in the last twelve months to 1.86B, up 3.03% year-over-year. In the year 2025, Autek China had annual revenue of 1.86B with 2.62% growth.
Revenue (ttm)
1.86B
Revenue Growth
+3.03%
P/S Ratio
4.83
Revenue / Employee
494.58K
Employees
3,752
Market Cap
8.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.86B | 47.54M | 2.62% |
| Dec 31, 2024 | 1.81B | 76.44M | 4.40% |
| Dec 31, 2023 | 1.74B | 211.85M | 13.89% |
| Jan 1, 2023 | 1.53B | 230.27M | 17.78% |
| Jan 1, 2022 | 1.30B | 424.38M | 48.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Blue Sail Medical | 6.61B |
| Tofflon Science and Technology Group | 5.34B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.35B |
| Shenyang Xingqi Pharmaceutical | 2.71B |
| Zhonghong Pulin Medical Products | 2.61B |
| Eyebright Medical Technology (Beijing) | 1.63B |
| Sansure Biotech | 1.61B |
| Aidite (Qinhuangdao) Technology | 1.13B |